Regulatory T-cells and effects of anti-CTLA4 and anti-PD1 therapy in a transgenic murine model of neuroblastoma

被引：0
|
作者：
Chan, Randall [1 ]
Shirinbak, Soheila [1 ]
Muthugounder, Sakunthala [1 ]
Hung, Long [1 ]
Gnanachandran, Janahan [1 ]
Hajidaniel, Michael [1 ]
Asgharzadeh, Shahab [1 ]
机构：
[1] USC Childrens Hosp Los Angeles, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant anti-CTLA4 and anti-PD1 blockade in advanced urothelial cancer
    Tregunna R.
    Nature Reviews Urology, 2020, 17 (12) : 658 - 658
  • [2] Response assessment to anti-CTLA4 or/and anti-PD1 immunotherapy in mucosal melanomas
    Moya-Plana, Antoine
    Herrera-Gomez, Ruth Gabriela
    Rossoni, Caroline
    Dercle, Laurent
    Ammari, Samy
    Girault, Isabelle
    Roy, Severine
    Scoazec, Jean-Yves
    Vagner, Stephan
    Janot, Francois
    Robert, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Combination therapy with anti-CTLA4 and anti-PD1 leads to distinct immunologic changes in-vivo
    Das, Rituparna
    Verma, Rakesh
    Sznol, Mario
    Boddupalli, Chadra Sekhar
    Gettinger, Scott
    Kluger, Harriet
    Dhodapkar, Madhav
    Dhodapkar, Kavita
    CANCER RESEARCH, 2015, 75
  • [4] Vogt-Koyanagi-Harada-like syndrome in the setting of combined anti-PD1/anti-CTLA4 therapy
    Godse, R.
    Mcgettigan, S.
    Schuchter, L. M.
    Ellebrecht, C. T.
    Chu, E. Y.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (06) : 1111 - +
  • [5] Enhancement of anti-PD1 and anti-CTLA4 efficacy by NBTXR3 nanoparticles exposed to radiotherapy
    Hu, Yun
    Zhang, Ping
    Darmon, Audrey
    Cortez, Maria Angelica
    Paris, Sebastien
    Welsh, James
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers
    Shklovskaya, Elena
    Pedersen, Bernadette
    Stewart, Ashleigh
    Simpson, Jack O. G.
    Ming, Zizhen
    Irvine, Mal
    Scolyer, Richard A.
    Long, Georgina, V
    Rizos, Helen
    CANCERS, 2022, 14 (19)
  • [7] Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
    Isaure Vanmeerbeek
    Daniel M. Borras
    Jenny Sprooten
    Oliver Bechter
    Sabine Tejpar
    Abhishek D. Garg
    Genes & Immunity, 2021, 22 : 108 - 119
  • [8] Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
    Vanmeerbeek, Isaure
    Borras, Daniel M.
    Sprooten, Jenny
    Bechter, Oliver
    Tejpar, Sabine
    Garg, Abhishek D.
    GENES AND IMMUNITY, 2021, 22 (02) : 108 - 119
  • [9] Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy
    Lee, J. H.
    Lim, S. Y.
    Menzies, A. M.
    Carlino, M. S.
    Guminski, A.
    Nahar, K.
    Palmieri, D.
    Breen, E.
    Kefford, R.
    Scolyer, R.
    Long, G. V.
    Rizos, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 659 - 659
  • [10] Comprehensive immunophenotypic profiling sheds light on the dynamic interplay between immune cells in the 4T1 breast cancer model upon anti-PD1 and anti-CTLA4 immunotherapy
    Nikolaou, Christos
    Heller, Simon
    Kaulfuss, Stefan
    Stresemann, Carlo
    Eichten, Alexandra
    von Ahsen, Oliver
    Lange, Martin
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345